These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3341783)

  • 1. [Treatment of prostatic cancer].
    Shimazaki J; Fuse H; Akimoto S; Akakura K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):212-8. PubMed ID: 3341783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer].
    Shimazaki J; Isaka S; Akakura K; Akimoto S; Morita S
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2092-7. PubMed ID: 9388518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
    Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
    Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prostatic carcinoma. I: Androgen dependency of prostatic carcinoma].
    Shimazaki J; Fuse H; Akimoto S; Sumiya H; Akakura K; Ichikawa T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):909-16. PubMed ID: 3389834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrine therapy of prostatic cancer].
    Shimazaki J; Fuse H; Zama S
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation.
    Zagars GK; Pollack A; von Eschenbach AC
    Cancer; 1997 Aug; 80(4):764-75. PubMed ID: 9264361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
    Faul P
    Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
    Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
    Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do radiotherapy and immediate orchiectomy yield comparable results as radical prostatectomy, adjuvant irradiation and orchiectomy in patients with stage D1 of prostatic carcinoma?].
    Wiegel T
    Strahlenther Onkol; 1995 Aug; 171(8):480-1. PubMed ID: 7652675
    [No Abstract]   [Full Text] [Related]  

  • 11. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
    Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
    J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of prostate cancer with regional lymph node (N1) metastasis.
    Pollack A; Horwitz EM; Movsas B
    Semin Radiat Oncol; 2003 Apr; 13(2):121-9. PubMed ID: 12728441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer].
    Akimoto S; Akakura K; Masai M; Shimazaki J
    Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results].
    Peneau M; Piéchaud T; Cariou G; Ragni E; Fontaine E; Fournier G
    Prog Urol; 1998 Dec; 8(6):977-93. PubMed ID: 9894256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma.
    Stein A; deKernion JB
    Semin Urol; 1990 Aug; 8(3):184-9. PubMed ID: 2119049
    [No Abstract]   [Full Text] [Related]  

  • 18. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
    Demanes DJ; Brandt D; Schour L; Hill DR
    Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors influencing prognosis of stage D2 prostatic cancer following endocrine therapy: comparison between short-term cancer death and long-term survival group].
    Masai M; Akimoto S; Isaka S; Shimazaki J; Yatani R
    Hinyokika Kiyo; 1990 Jun; 36(6):667-71. PubMed ID: 1700585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of patients with clinical stage C prostate cancer treated by phototherapy and early orchiectomy. A retrospective analysis of 169 cases.
    Wiegel T; Tepel J; Schmidt R; Klosterhalfen H; Arps H; Berger P; Franke HD
    Strahlenther Onkol; 1996 Nov; 172(11):596-603. PubMed ID: 8946031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.